More MS news articles for July 2002

Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12086750&dopt=Abstract

Trends Neurosci 2002 Jun;25(6):313-9
Neumann H, Medana IM, Bauer J, Lassmann H.
Neuroimmunology Unit, European Neuroscience Institute Gottingen, Waldweg 33, 37073, Gottingen, Germany

Cytotoxic T lymphocytes (CTLs) with a CD8(+) phenotype have the potential to recognize and attack major histocompatibility complex (MHC) class I-expressing brain cells.

Most brain cells, including neurons, can be stimulated to present peptides to CD8(+) CTLs by MHC class I molecules, and are susceptible to CTL-mediated cytotoxicity in culture.

In disease-affected brain parenchyma, CD8(+) CTLs outnumber other T-cell subtypes.

They show clonal expansion in several inflammatory and degenerative CNS diseases, such as multiple sclerosis (MS), virus-induced inflammatory brain diseases and paraneoplastic neurological disorders.

In MS, damage of axons is closely linked to the CD8(+) CTLs, and protection against CTL-mediated damage should be considered as a new therapeutic approach in MS and other neuroinflammatory diseases.